Monte Rosa Therapeutics: Q4 Earnings Snapshot

By The Associated Press
March 17, 2026 | 7:36 AM

BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Tuesday reported a loss of $46.1 million in its fourth quarter.

The Boston-based company said it had a loss of 55 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.

The biopharmaceutical company posted revenue of $2.8 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $10.3 million.

For the year, the company reported a loss of $38.6 million, or 46 cents per share. Revenue was reported as $123.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE

Australia beats Turkey for 2nd win at Women’s Basketball World Cup, U.S. plays Italy later

By The Associated Press
September 6, 2026 | 7:50 AM

BERLIN (AP) — Ezi Magbegor scored 21 points as Australia reached the final phase of the Women’s Basketball World Cup with a physical 87-71 win over Turkey on Sunday. Turkey, led by Sevgi Uzun with 24 points, was down 8-0 at the start but fought back after a timeout to lead 15-14. That was brief, however, as the Opals rallied to end the first quarter 21-15 up and they did not relinquish the lead for the rest of the game. Turkey’s Goksen Fitik went off with what appeared to be a right-ankle injury in the third quarter but she returned in the fourth. The Australian team features seven World Cup debutants. Team captain Sami Whitcomb of the WNBA’s Phoenix Mercury had to withdraw before the tournament with a lingering knee injury.

Related Stories